Home › Interstitial Lung Diseases › California › Los Angeles
Interstitial Lung Diseases clinical trials in Los Angeles, CA
14 studies for Interstitial Lung Diseases are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RecruitingPhase 3
- University of Southern California, Los Angeles
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RecruitingPhase 3
- University of California Los Angeles, Los Angeles
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 3
- USA010, Los Angeles
- USA023, Los Angeles
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
RecruitingPhase 3
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RecruitingPhase 3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RecruitingPhase 3
- David Geffen School of Medicine at UCLA, Los Angeles
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Cedars-Sinai Medical Center, Los Angeles
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- Peter Morton Medical Building, Los Angeles
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Keck School of Medicine of USC, Los Angeles
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RecruitingPhase 2
- aTyr Investigative Site, Los Angeles
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Kansas City, KS13 studies
- Durham, NC13 studies
- Charleston, SC13 studies
- Chicago, IL12 studies
- Houston, TX12 studies
- Aurora, CO11 studies
- Ann Arbor, MI11 studies
- Phoenix, AZ9 studies
- Salt Lake City, UT9 studies
- Boston, MA9 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer72 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.